|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/30 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| C12N 5/12 |
| (11) | Number of the document | 2152754 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08758782.0 |
| Date of filing the European patent application | 2008-05-27 | |
| (97) | Date of publication of the European application | 2010-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/004197 |
| Date | 2008-05-27 |
| (87) | Number | WO 2008/145338 |
| Date | 2008-12-04 |
| (30) | Number | Date | Country code |
| 07010622 | 2007-05-29 | EP | |
| 932099 P | 2007-05-29 | US |
| (72) |
SAHIN, Ugur, DE
TÜRECI, Özlem, DE
BRANDENBURG, Gunda, DE
USENER, Dirk, DE
|
| (73) |
Astellas Pharma Inc.,
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411,
JP
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb, Freiligrathstrasse 12, 55131 Mainz, DE |
| (54) | MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER |
| MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER |